Table 1 Candidate genes identified by trio pooled-WES in this study.

From: Accurate and cost-effective workflow integrating trio pooled-WES for novel gene discovery in neurodevelopmental disorders

Gene

Zigosity

Inheritance

Variant Type

gnomAD MAF

Domino Score

In silico predictors

Gene intolerance scores

Rationale for inclusion as a candidate gene

REVEL

CADD

AlphaMissense

SIFT

SpliceAI

PhyloP

pLi

Missense Z score

APOO

Heterozygous

De novo

Stopgain

0.000000912

38

3.95

De novo LoF variant, observed in a single individual in gnomAD, within an X-linked gene previously suggested as a candidate for NDD [42].

CCR7

Heterozygous

De novo

Missense

0.7

0.73

26.8

0.986

0

7.84

2.69

De novo missense variant in a likely dominant gene; unanimously predicted deleterious, absent from gnomAD, and affecting a highly conserved residue

CDC42BPA

Heterozygous

De novo

Frameshift

0.6

9.325

1

De novo LoF variant in a likely dominant, haploinsufficient gene, absent from gnomAD.

MAPK7

Heterozygous

De novo

Missense

0.00000137

0.9

0.82

27

0.993

0

5.796

2.09

De novo missense variant in a likely dominant gene; unanimously predicted deleterious, observed in a single individual in gnomAD, and affecting a highly conserved residue

MED1

Heterozygous

De novo

Frameshift

0.9

9.633

1

De novo LoF variant in a likely dominant, haploinsufficient gene, absent from gnomAD.

PITPNM2

Heterozygous

De novo

Missense

0.7

0.6

25.3

0.777

0

7.803

4.33

De novo missense variant in a likely dominant gene, intolerant to missense variation. The variant is unanimously predicted to be deleterious by in silico tools, absent from gnomAD, and affects a highly conserved residue.

PTPRT

Heterozygous

De novo

Missense

0.9

0.85

24.9

0.989

0.01

9.809

3.22

De novo missense variant in a likely dominant gene, intolerant to missense variation. The variant is unanimously predicted to be deleterious by in silico tools, absent from gnomAD, and affects a highly conserved residue.

RYR3

Heterozygous

De novo

Splicing

0.9

34

0.96

9.993

1

De novo splice-site variant, absent from gnomAD and predicted to alter splicing at a highly conserved residue. The variant is located in a likely dominant, haploinsufficient gene previously proposed as a candidate for NDD [43]

TRADD

Heterozygous

De novo

Stopgain

0.8

35

  

0.773

0.01

De novo LoF variant in a likely dominant gene. The variant is absent from gnomAD.

ZBTB17

Heterozygous

De novo

Frameshift

0.9

5.478

1

De novo LoF variant in a likely dominant, haploinsufficient gene, absent from gnomAD.

ZNF608

Heterozygous

De novo

Stopgain

0.9

39

2.409

1

De novo LoF variant in a likely dominant, haploinsufficient gene, absent from gnomAD.

ZNF75D

Hemizygous

Maternal

Splicing

23.2

0.6

0.687

Hemizygous splicing variant in an X-linked gene, inherited from the mother. In silico predictors indicate an alteration of splicing, and the variant is absent from gnomAD.

ANGPTL2

Homozygous

Biallelic

Stopgain

0.00000205

44

2.776

0.01

Homozygous LoF variant in a likely recessive gene; low pLI (haploinsufficiency metric, not indicative of recessive genes). No LoF variants reported in homozygosity in gnomAD.